Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dphansti
    Member
    • May 2011
    • 28

    #1

    Viewing PET data in IGV

    I have a bed file from PET data in this format

    chr17 58754953 58754971 pair1 23 -
    chr17 58755650 58755672 pair1 25 +
    chr13 93209287 93209313 pair2 37 +
    chr13 93209438 93209457 pair2 20 -

    etc.

    I want to plot it in IGV so each pair is represented as it is in the attached figure where each read is represented as a box with a line connecting the two members of each pair. What format do I need to convert my data into? Or how can I view it this way.
    Attached Files
    Doug
    www.sharedproteomics.com
  • dphansti
    Member
    • May 2011
    • 28

    #2
    Nevermind. I figured it out. I made a .gff file and treated each pair like an exon from a gene.
    Doug
    www.sharedproteomics.com

    Comment

    • Jim Robinson
      Member
      • May 2009
      • 75

      #3
      Hi,

      That will work, you can also use bed format but you have to use the extended form. See the UCSC site for details. BED files have the advantage of being much smaller, in general, and can also be indexed or converted to "bigBed".

      Jim

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        How Immunogenomics Decodes Immunity’s Genetic Blueprint
        by SEQadmin2




        The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

        This convergence of genetics, immunology, and computation...
        Today, 05:41 AM
      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-24-2026, 10:32 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-20-2026, 11:17 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-18-2026, 10:05 AM
      0 responses
      54 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      50 views
      0 reactions
      Last Post SEQadmin2  
      Working...